Mezlocillin pharmacokinetics in pediatric oncology patients.
The pharmacokinetics of mezlocillin were studied in 31 children (age, 2 to 19 years) with malignancies and normal renal and hepatic functions. Mezlocillin was administered intravenously over 30 min every 4 h at doses ranging from 12.2 to 125 mg/kg. Blood samples were obtained over one dosage interva...
保存先:
| 出版年: | Antimicrob Agents Chemother |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology (ASM)
1984
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC185436/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6703685/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.25.1.62 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|